《半日總結》恆指升24點 中銀及內房股揚 醫藥股受壓
市場關注內地科網巨擘規管,港股在勞動節長週末後復市,隨亞太區早市靠穩。恆指低開161點,早段曾跌440點一度低見20,648點,其後倒升,半日升24點或0.12%,報21,114點;國指跌19點或0.27%,報7,278點;恆生科技指數跌41點或0.93%,報4,430點。大市半日成交總額673.09億元,內地五一長假期休市,滬、深港通南下交易5月5日重啓。
科技股方面,嗶哩嗶哩(09626.HK)下調首季淨營業額指引,半日股價跌2.3%報198.9元。小米(01810.HK)被印度扣押當地銀行逾7億美元存款,半日股價跌3.9%報11.72元。騰訊(00700.HK)升0.7%報380元,阿裏巴巴(09988.HK)跌1.6%報100.5元,美團(03690.HK)升1.8%報175.1元,京東(09618.HK)跌4.2%報254.4元,百度(09888.HK)跌3%報126.7元。
金融股方面,中銀香港(02388.HK)半日股價彈高4.7%收30元,券商指其首季營運溢利勝市場預期,爲半日股價升幅最大藍籌股。匯控(00005.HK)升1%報49.45元,港交所(00388.HK)升1.8%報343.8元,友邦(01299.HK)平收報77.75元。招行(03968.HK)及工行(01398.HK)各跌1.5%及1.7%。
中信銀行(00998.HK)建議AH同步供股最多籌400億人民幣,股價挫7.5%。民行(01988.HK)首季少賺近7%遭瑞信下調目標價,半日股價跌3%。郵儲行(01658.HK)首季多賺18%,股價升3.2%。
內房股造好,遠洋集團(03377.HK)贖回4.98億美元票據,早市股價升6.7%,中海外(00688.HK)、中國金茂(00817.HK)、旭輝(00884.HK)、龍湖(00960.HK)、碧桂園(02007.HK)及萬科(02202.HK)各升3.5%至4.4%。
醫藥股受壓,和黃醫藥(00013.HK)癌症治療藥物赴美上市被拒,早市股價挫18%。康希諾醫藥(06185.HK)跌7%,信達生物(01801.HK)跌5.4%,綠葉製藥(02186.HK)及復星醫藥(02196.HK)各跌4%及4.1%,中生製藥(01177.HK)跌3.4%。
金價下跌,山東黃金(01787.HK)及招金(01818.HK)各跌3.9%及5.1%。汽車股理想(02015.HK)跌4.3%,蔚來(09866.HK)及長汽(02333.HK)各跌3.1%及3.5%。其他消費及內需股方面,海爾智家(06690.HK)升5.6%,頤海(01579.HK)升4.9%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.